Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine

Cephalalgia

Volumn 34, Issue 6, 2014, Pages 464-472

  Conforto, Adriana B ^a,b   Amaro, Edson ^a,b   Gonçalves, André L ^a   Mercante, Juliane P P ^a   Guendler, Vera Z ^a   Ferreira, Josione R ^a   Kirschner, Clara C F B ^a   Peres, Mario F P ^a,c  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

chronic migraine; dorsolateral prefrontal cortex; pain; Placebo; transcranial magnetic stimulation

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; DISABILITY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PLACEBO EFFECT; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL; SAFETY; SOMNOLENCE; TRANSCRANIAL MAGNETIC STIMULATION; TRANSFORMED MIGRAINE; TREATMENT OUTCOME; FEASIBILITY STUDY; MALE; MIGRAINE DISORDERS; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; DOUBLE-BLIND METHOD; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84899000445     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413515340     Document Type: Article

References (36)

1. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: A systematic review. Cephalalgia. 2010; 30: 599-609
2. Queiroz LP, Peres MFP, Kowacs F, et al. Chronic daily headache in Brazil: A nationwide population-based study. Cephalalgia. 2008; 28: 1264-1269
3. Diener HC, Holle D, Dodick D. Treatment of chronic migraine. Curr Pain Headache Rep. 2011; 15: 64-69
4. Ridding MC, Rothwel JC. Is there a future for therapeutic use of transcranial magnetic stimulation?. Nature Rev Neurosci. 2007; 8: 559-567
5. Avery DH, Holtzheimer PE, Fawaz W, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006; 59: 87-94
6. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol Psychiatry. 2007; 62: 1208-1216
7. Antonaci F, Nappi G, Galli F, et al. Migraine and psychiatric comorbidity: A review of clinical findings. J Headache Pain. 2011; 12: 115-125
8. Mercante JP, Peres MF, Guendler V, et al. Depression in chronic migraine: Severity and clinical features. Arq Neuropsiquiatr. 2005; 63: 217-220
9. Zwanzger P, Fallgatter AJ, Zavorotnyy M, et al. Anxiolytic effects of transcranial magnetic stimulation-an alternative treatment option in anxiety disorders?. J Neural Transm. 2009; 116: 767-775
10. Mongini F, Keller R, Deregibus A, et al. Frontal lobe dysfunction in patients with chronic migraine: A clinical-neuropsychological study. Psychiatry Res. 2005; 133: 101-106
11. Avery DH, Holtzheimer PE, Fawaz W, et al. Transcranial magnetic stimulation reduces pain in patients with major depression: A sham-controlled study. J Nerv Ment Dis. 2007; 195: 378-381
12. Brighina F, Piazza A, Vitello G, et al. rTMS of the prefrontal cortex in the treatment of chronic migraine: A pilot study. J Neurol Sci. 2004; 227: 67-71
13. Ziemann U. TMS and drugs. Clin Neurophysiol. 2004; 115: 1717-1729
14. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-746
15. Conforto AB, Z'Graggen WJ, Kohl AS, et al. Impact of coil position and electrophysiological monitoring on determination of motor thresholds to transcranial magnetic stimulation. Clin Neurophysiol. 2004; 115: 812-819
16. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999; 53: 988-994
17. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 561-571
18. Andrade L, Gorenstein C, Vieira Filho AH, et al. Psychometric properties of the Portuguese version of the State-Trait Anxiety Inventory applied to college students: Factor analysis and relation to the Beck Depression Inventory. Braz J Med Biol Res. 2001; 34: 367-374
19. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986; 73: 13-22
20. Diener HC, Kronfeld K, Boewing G, et al. Efficacy of acupuncture for the prophylaxis of migraine: A multicentre randomised controlled clinical trial. Lancet Neurol. 2006; 5: 310-316
21. Linde K, Streng A, Jürgens S, et al. Acupuncture for patients with migraine. A randomized controlled trial. JAMA. 2005; 293: 2118-2125
22. Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2008; 11: 131-147
23. Machii K, Cohen D, Ramos-Estebanez C, et al. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol. 2006; 117: 455-471
24. Misra UK, Kalita J, Bhoi S. High-rate repetitive transcranial magnetic stimulation in migraine prophylaxis: A randomized placebo-controlled study. J Neurol. 2013; 260: 2793-2801-2793-2801
25. Aurora SK, Dodick DW, Turkel CC, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010; 30: 793-803
26. Silvanto J, Muggleton N, Walsh V. State-dependency in brain stimulation studies of perception and cognition. Trends in Cogn Sci. 2008; 12: 447-454
27. Speciali JG, Peres M, Bigal ME. Migraine treatment and placebo effect. Expert Rev Neurother. 2010; 10: 413-419
28. Strafella AP, Ko JH, Monchib O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: The contribution of expectation. Neuroimage. 2006; 31: 1666-1672
29. Teepker M, Hötzel J, Timmesfeld N, et al. Low-frequency rTMS of the vertex in the prophylactic treatment of migraine. Cephalalgia. 2009; 30: 137-144
30. Nieoullon A, Cheramy A, Glowinski J. Nigral and striatal dopamine release under sensory stimuli. Nature. 1977; 269: 340-342
31. Proietti-Cecchini A, Afra J, Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: Demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig®). Cephalalgia. 1997; 17: 849-854
32. Currà A, Coppola G, Gorini M, et al. Drug-induced changes in cortical inhibition in medication overuse headache. Cephalalgia. 2001; 31: 1282-1290
33. Diener HC, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004; 3: 475-483
34. Tamura Y, Okabe S, Ohnishi T, et al. Effects of 1-Hz repetitive transcranial magnetic stimulation on acute pain induced by capsaicin. Pain. 2004; 107: 107-115
35. Lefaucheur JP, Drouot X, Nguyen JP. Interventional neurophysiology for pain control: Duration of pain relief following repetitive transcranial magnetic stimulation of the motor cortex. Neurophysiol Clin. 2001; 31: 247-252
36. Dasilva AF, Mendonca ME, Zaghi S, et al. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache. 2012; 52: 1283-1295